4151.T
Kyowa Kirin Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 2,430.00
+1.67%Year over year
Reported trailing growth
- Revenue
- +3.2%
- EBITDA
- —
- EBIT
- —
- EPS
- +44.0%
- Free cash flow
- +350.7%
- Operating cash flow
- +165.6%
Forward estimates
Based on analyst estimates
- Revenue
- +1.8%
- EBITDA
- —
- EPS
- +2.9%
Three-year CAGR
- Revenue
- +7.6%
- EBITDA
- +9.6%
- EBIT
- +8.9%
- Net income
- +7.8%
- EPS
- +8.7%
- Free cash flow
- +21.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026